Sponsor Pipeline

Sichuan Baili Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
44
Active Trials
24
Recruiting
23
Phase 3
10
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07518147
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in…
Recruitment opened
2026-06-05 NCT07518173
A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and…
Recruitment opened
2026-05-29 NCT07591155
A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-11 NCT07640789 A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in… Phase 3 Not Yet Recruiting
2026-06-11 NCT07641855 A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant… Phase 2/3 Not Yet Recruiting
2026-06-11 NCT07642024 A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients… Phase 2/3 Not Yet Recruiting
2026-05-26 NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… Phase 3 Not Yet Recruiting
2026-05-26 NCT07606612 A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors Phase 1 Not Yet Recruiting
2026-05-15 NCT07591155 A Study of BL-ARC002 in Patients With Locally Advanced or Metastatic Solid Tumors Phase 1 Recruiting
2026-05-15 NCT07591168 A Study of BL-M11D1 in Patients With Relapsed/Refractory Myelodysplastic Syndromes Phase 1/2 Not Yet Recruiting
Active Trials by Phase
Phase 3
19
Phase 2/3
4
Phase 2
7
Phase 1/2
2
Phase 1
12
Active Trials — top 25 of 44
NCT IDTitleConditionStatus
Phase 3
NCT06957886 A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With… HER2-low Breast Cancer Recruiting
NCT06830889 A Study of BL-M07D1 Versus T-DM1 in the Adjuvant Treatment of HER2-positive Breast Cancer… HER2-positive Breast Cancer Recruiting
NCT06838273 A Study of BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line… Non-small Cell Lung Cancer Recruiting
NCT06857175 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Urothelial Carcinoma Recruiting
NCT06994195 A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients… Epithelial Ovarian Cancer Recruiting
NCT07518147 A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in… Gastric Cancer Recruiting
NCT07518173 A Study of BL-M07D1 Combined With Pertuzumab Versus Docetaxel Plus Trastuzumab and… HER2-positive Breast Cancer Recruiting
NCT06118333 A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With… Nasopharyngeal Carcinoma Active, Not Recruiting
NCT06304974 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Esophageal Squamous Cell Carcinoma Active, Not Recruiting
NCT06343948 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… HR+HER2- Breast Cancer Active, Not Recruiting
NCT06382116 A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally… Non-small Cell Lung Cancer Active, Not Recruiting
NCT06382129 A Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced… Non-small Cell Lung Cancer Active, Not Recruiting
NCT06500026 A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung… Small Cell Lung Cancer Active, Not Recruiting
NCT06382142 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With… Triple-Negative Breast Cancer Active, Not Recruiting
NCT07502300 A Study Comparing BL-B01D1 Combined With Tislelizumab Versus Platinum-containing… Extensive-stage Small-cell Lung Cancer Not Yet Recruiting
NCT07545460 A Study Comparing BL-M07D1 With Physician's Choice of Chemotherapy in Patients With… Epithelial Ovarian Cancer Not Yet Recruiting
NCT07582315 A Study Comparing BL-B01D1 With Treatment of Physician's Choice in Patients With Locally… Biliary Tract Cancer Not Yet Recruiting
NCT07606599 A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With… Biliary Tract Cancer Not Yet Recruiting
NCT07640789 A Study Comparing BL-B01D1 in Combination With Osimertinib Versus Osimertinib Alone in… Non-small Cell Lung Cancer Stage III Not Yet Recruiting
Phase 2/3
NCT07255872 A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax +… Acute Myeloid Leukemia Not Yet Recruiting
NCT07554456 A Study of BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus… Esophageal Squamous Cell Carcinoma Not Yet Recruiting
NCT07641855 A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant… Castration-resistant Prostate Cancer Not Yet Recruiting
NCT07642024 A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients… Non-small Cell Lung Cancer Not Yet Recruiting
Phase 2
NCT06668961 A Study of SI-B001+SI-B003 Combined With Platinum-based Chemotherapy as First-line… Head and Neck Squamous Cell Carcinoma Recruiting
NCT07054567 A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or… Cervical Cancer Recruiting
View all 44 active Sichuan Baili Pharmaceutical Co., Ltd. trials with filters →
Disease Areas
Get alerts when Sichuan Baili Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free